These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6542049)

  • 1. Pelvic irradiation plus adriamycin and cyclophosphamide in selected patients with epithelial ovarian carcinoma: a phase II study of the Northern California Oncology Group.
    Ballon SC; Martinez A; Turbow MM; Koretz MM; Carter SK
    Gynecol Oncol; 1984 Nov; 19(3):278-83. PubMed ID: 6542049
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoimmunotherapy for advanced ovarian carcinoma with adriamycin-cyclophosphamide +/- BCG: early report of a Southwest Oncology Group study.
    Alberts DS; Salmon SE; Moon TE
    Recent Results Cancer Res; 1978; 68():160-5. PubMed ID: 752854
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.
    Wils J; Blijham G; Naus A; Belder C; Boschma F; Bron H; Ceelen T; Eekhout A; von Erp J; Geelen P
    J Clin Oncol; 1986 Jul; 4(7):1068-73. PubMed ID: 3723166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytoreductive surgery plus combined chemotherapy for the treatment of advanced ovarian cancer].
    Li M; Huang X
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):621-3. PubMed ID: 9275460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.
    Ehrlich CE; Einhorn L; Williams SD; Morgan J
    Cancer Treat Rep; 1979 Feb; 63(2):281-8. PubMed ID: 376134
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized study of chemoimmunotherapy for advanced ovarian carcinoma: a preliminary report of a Southwest Oncology Group study.
    Alberts DS; Moon TE; Stephens RA; Wilson H; Oishi N; Hilgers RD; O'Toole R; Thigpen JT
    Cancer Treat Rep; 1979 Feb; 63(2):325-31. PubMed ID: 376137
    [No Abstract]   [Full Text] [Related]  

  • 7. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.
    Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM
    Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378
    [No Abstract]   [Full Text] [Related]  

  • 8. Single-agent adriamycin followed by combination hexamethylmelamine-cyclophosphamide for advanced ovarian carcinoma.
    Wharton JT; Herson J; Edwards CL; Griffith AB
    Gynecol Oncol; 1982 Oct; 14(2):262-70. PubMed ID: 6813202
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.
    Bruckner HW; Ratner LH; Cohen CJ; Wallach R; Kabakow B; Greenspan EM; Holland JF
    Cancer Treat Rep; 1978 Jul; 62(7):1021-3. PubMed ID: 688244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.
    Bruckner HW; Pagano M; Falkson G; Creech R; Arseneau JC; Horton J; Brodovsky H; Davis TE; Slayton RW; Greenspan E
    Cancer Treat Rep; 1979 Feb; 63(2):297-9. PubMed ID: 376136
    [No Abstract]   [Full Text] [Related]  

  • 11. Polychemotherapy in ovarian cancer: treatment with Adriamycin, BCNU and cyclophosphamide vs. Adriamycin and cyclophosphamide.
    Mazzei T; Bonazza M; Amunni G; Scarselli G; Branconi F; Massi GB
    Chemioterapia; 1984 Feb; 3(1):10-5. PubMed ID: 6535650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts in cancer: ovary--treatment for stages III and IV. The multimodal approach to the treatment of stage III ovarian carcinoma.
    Fuks Z; Rizel S; Anteby SO; Biran S
    Int J Radiat Oncol Biol Phys; 1982 May; 8(5):903-8. PubMed ID: 6809711
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study.
    Randall ME; Barrett RJ; Spirtos NM; Chalas E; Homesley HD; Lentz SL; Hanna M
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):139-47. PubMed ID: 12118543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possible incompatibility of deep radiotherapy and high-dose adriamycin or cyclophosphamide therapy in advanced genital tumors of the female].
    Wolf A; Bork E; Vahrson H
    Strahlentherapie; 1976 Nov; 152(5):422-6. PubMed ID: 996885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
    Chylak V; Ilijas M; Krusić J; Kolarić K
    Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiotherapeutic management of ovarian cancer.
    Dembo AJ
    Semin Oncol; 1984 Sep; 11(3):238-50. PubMed ID: 6435249
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognostic factors of common epithelial ovarian cancer treated by surgery and cisplatin based combination chemotherapy].
    Sasaki H; Ochiai K; Terashima Y; Mochizuki S; Soda T; Nishimura H; Yakushiji M; Hirabayashi M
    Gan No Rinsho; 1989 Oct; 35(13):1615-20. PubMed ID: 2585733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma.
    Kane R; Harvey H; Andrews T; Bernath A; Curry S; Dixon R; Gottlieb R; Kukrika M; Lipton A; Mortel R; Ricci J; White D
    Cancer Treat Rep; 1979 Feb; 63(2):307-9. PubMed ID: 109201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of postoperative radiotherapy with postoperative chemotherapy in stage II-IV ovarian cancer patients.
    Menczer J; Ben-Baruch G; Modan M; Brenner J; Brenner H
    Gynecol Oncol; 1984 Feb; 17(2):207-12. PubMed ID: 6546732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential cisplatin/cyclophosphamide chemotherapy and abdominopelvic radiotherapy in the management of advanced ovarian cancer.
    Green JA; Warenius HM; Errington RD; Myint S; Spearing G; Slater AJ
    Br J Cancer; 1988 Nov; 58(5):635-9. PubMed ID: 3219276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.